Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | THRN | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -$160M | -15.7M | -100% | $10.20 | 0 | Oct 12, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | THRN | Warrants (right to buy) | Exercise of in-the-money or at-the-money derivative security | -56.5K | -100% | 0 | Oct 12, 2023 | Common Stock | 56.5K | $5.12 | Direct | F2 |
Kirin Holdings Company, Ltd /FI is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated August 27, 2023 (the "Merger Agreement"), by and among the Issuer, Healthspan Buyer, LLC, a Delaware limited liability company ("Parent"), and Healthspan Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of Parent ( "Purchaser"), which contemplates the a tender offer to purchase all of the outstanding shares of Issuer common stock at a price of $10.20 per share in cash, without interest, less any required withholding taxes (the "Offer Price"), and the consummation of the merger between the Issuer and Purchaser. |
F2 | Pursuant to the Merger Agreement, each warrant which had a per share exercise price that was less than the Offer Price that was then outstanding and unexercised as of immediately before the Effective Time (as defined in the Merger Agreement) was automatically cancelled and converted into a right to receive an amount in cash, without interest, equal to the product of (i) the Offer Price (less the exercise price per share attributable to such warrant) multiplied by (ii) the total number of shares of Issuer common stock issuable upon exercise in full of such warrant. |